Assure Holdings Corp

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. The firm employs trained technologists that provide a direct point of contact in the operating room. Its physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure, communicating in real-time with the surgeon and technologist. The company was founded by Preston Thomas Parsons on May 24, 2017 and is headquartered in Englewood, CO.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. The firm employs trained technologists that provide a direct point of contact in the operating room. Its physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure, communicating in real-time with the surgeon and technologist. The company was founded by Preston Thomas Parsons in 2016 and is headquartered in Denver, CO.

DENVER, April 19, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today a change to its management team. As of the date hereof, Assure is ending its employment relationship with Company founder Preston Parsons.

Assure Holdings Announces Change to Management Team

Company Begins Providing Services in Thirteenth State Company Begins Providing Services in Thirteenth State

Assure Holdings Performs First Neuromonitoring Case in Minnesota

Kelly Shelton Appointed Vice President of Sales and Sherri Wagner Named Vice President of Human Resources Kelly Shelton Appointed Vice President of Sales and Sherri Wagner Named Vice President of Human Resources

Assure Announces Hiring of Two Senior Executives to Support Growth

Assure Holdings Corp. (IONM) CEO John Farlinger on Q4 2021 Results - Earnings Call Transcript

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -50% and 8.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q4 Loss, Tops Revenue Estimates

Full Year 2021 Managed Case Volume Increased 76% to 17,436

Assure Holdings Reports Fourth Quarter and Full Year 2021 Financial Results

Assure Holdings Corp. (IONM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Strength Seen in Assure Holdings Corp. (IONM): Can Its 7.3% Jump Turn into More Strength?

DENVER, March 08, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in March and April 2022:

Assure to Attend Investor Conferences in March and April 2022

There are unfounded concerns that private insurance for IONM could be reduced or terminated. The company has improved its operations and demonstrated an ability to grow organically and by acquisitions but the stock price has languished.

Investors Are Unsure About Assure, But I Am Not

DENVER, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring services (“IONM”), announced that Brian McDonald was appointed vice president of business operations.

Assure Appoints Brian McDonald as Vice President of Business Operations

DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced an annual, quarterly and monthly record for managed cases in the full-year period, the fourth quarter and the month of December 2021.

Assure Sets Managed Cases Record for Full-Year, Fourth Quarter and Month of December 2021

DENVER, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announces that it has applied to voluntarily delist its common shares (the “Common Shares”) from the TSX Venture Exchange (the “TSXV”). Accordingly, it is anticipated that, effective as at the close of markets on February 7, 2022, the Common Shares will no longer be traded on the TSXV and will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “IONM”. Upon completion of the delisting, Canadian shareholders will be able to continue to trade their Common Shares on the Nasdaq.

Assure Announces Voluntary Delisting from TSX Venture Exchange

DENVER, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced that its remote neurology business, which launched in 2021, performed more than 2,100 remote neurology managed cases during the year. This included 1,222 in the fourth quarter of 2021, which exceeded the Company's forecasted range of 1,000 to 1,200 during the period.

Assure Exceeds Fourth Quarter 2021 Forecast for Remote Neurology Managed Cases

DENVER, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced that it is scheduled to present at the AlphaNorth Capital Investment Conference on March 25-27, 2022.

Assure to Participate in the AlphaNorth Capital Conference

DENVER, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced record monthly managed cases during November 2021.

Assure Reports a Record Number of Monthly Managed Cases in November 2021

DENVER, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce that the Company completed a non-brokered private placement, with participation by Assure management and certain directors, employees and consultants, of 70,300 common shares of the Company (“Common Shares”) at an issue price of US$6.19 per share, for aggregate gross proceeds of approximately US$435,000 (the “Offering”). The issue price was determined in the context of the market and in accordance with Nasdaq listing requirements and following the end of the Company's trading blackout period under its insider trading policy.

Assure Closes $5.2 Million from Institutional Investor Led and Management and Board Driven Private Placements

DENVER, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced that management will participate in the following investor conferences in December 2021:

Assure to Attend Investor Conferences in December 2021

DENVER, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce that the Company intends to complete a non-brokered private placement, with participation by Assure management, the board of directors and certain employees and consultants, of up to 70,300 common shares of the Company (“Common Shares”) at an issue price of US$6.19 per Common Share, for aggregate gross proceeds of up to approximately US$435,000 (the “Offering”). The issue price was determined in the context of the market and in accordance with Nasdaq listing requirements and following the end of the Company's trading blackout period under its insider trading policy.

Assure Announces $435,000 Private Placement with Management and Board Participation

DENVER, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce that it has entered into an amending agreement (the “Amending Agreement”) to its Commitment Letter dated March 8, 2021 (the “Commitment Letter”), with Centurion Financial Trust, an investment trust managed by Centurion Asset Management Inc. (“Centurion”) in respect of the Company's $11,000,000 credit facility (the “Credit Facility”) with Centurion comprised of a $9,000,000 senior term loan (the “Senior Term Loan”), funded in two tranches of $6,000,000 and $3,000,000, and a $2,000,000 senior revolving loan (the “Revolving Loan”). The first tranche of the Senior Term Loan and the Revolving Loan were previously funded.

Assure Announces Amendment to Credit Facility to Allow Funding of Second Tranche of the Senior Term Loan for Working Capital Purposes, Increasing Access to Previously Restricted Line of Credit

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of 112.50% and 25.68%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Q3 Earnings and Revenues Surpass Estimates

Assure Holdings Corp. (IONM) CEO John Farlinger on Q3 2021 Results - Earnings Call Transcript

DENVER, Nov. 15, 2021 (GLOBE NEWSWIRE) --  Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce the closing of a brokered private placement whereby the Company issued approximately 900,000 shares generating gross proceeds of US$4.75 million at an issue price of US$5.25 per share (the “Offering”). There were no warrants issued in connection with the Offering.

Assure Holdings Announces Closing $4.75 Million Private Placement to Accelerate 2022 Growth

DENVER, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH; OTCQB: ARHHD*), a provider of intraoperative neuromonitoring services (“IONM”), announced that its shares of common stock were approved for listing on the NASDAQ Capital Market (“NASDAQ”). Trading on NASDAQ is scheduled to commence on September 29, 2021, under the ticker symbol “IONM.”

Assure Approved for Listing on NASDAQ Capital Market Under New Symbol “IONM”

DENVER, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH; OTCQB: ARHHD*), a provider of intraoperative neuromonitoring services (“IONM”), announced that management will participate in the Lake Street 5th Annual Best Ideas Growth (BIG5) Conference on Wednesday, September 15th, 2021.

Assure to Participate in the Lake Street 5th Annual Best Ideas Growth (BIG5) Conference

DENVER, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (“IONM”), effected a reverse stock split (“Reverse Split”) of its shares of common stock at a ratio of 5 (old) for 1 (new) ratio at 5:30 p.m. (Eastern Time), and filed a Form 8-A with the Securities and Exchange Commission (“SEC”) to register its common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended, for the purpose of qualifying to uplist on the NASDAQ Capital Market (“NASDAQ”).

News for Assure Holdings Corp Stock (IONM)